NTLA Stock Analysis: Buy, Sell, or Hold?
NTLA - Intellia Therapeutics, Inc
$14.22
-1.22 (-7.93%)
▼
5d:
-19.05%
30d:
+10.28%
90d:
+2.78%
WAIT
LOW Confidence
Analysis Updated: Jul 10, 2026 12:00 AM ET
Earnings: Aug 06, 2026
23d
Smart Money Distribution
None View Scanner →
Strength: 7.4/10
Get Alerted When NTLA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called NTLA this week
67% bullish • 2 bearish
67% bullish • 2 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: NTLA is down 19.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: NTLA is down 19.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: NTLA is currently trading at $14.21, which is considered fair relative to its 30-day fair value range of $13.31 to $16.75.
Technical Outlook: Technically, NTLA is in a uptrend. The price is currently testing key support at $14.10. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.9% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $26.33 (+85.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NTLA is in a uptrend. The price is currently testing key support at $14.10. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.9% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $26.33 (+85.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$13.31 -
$16.75
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
69.5%
Protect Your Profits
Holding NTLA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.9%)
- BULLISH: Trading 85.3% below Wall St target ($26.33)
- WARNING: Recommendation downgraded due to -19.0% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$13.31 -
$16.75
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$14.10
Resistance Level
$18.48
Current Trend
Uptrend
Technical data as of
Jul 10, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-8.30
Wall Street Target
$26.33
(+85.3%)
Revenue Growth (YoY)
-9.5%
Share & Embed Analysis
Last updated: July 13, 2026 6:45 AM ET
Data refreshes hourly during market hours. Next update: 7:45 AM
Data refreshes hourly during market hours. Next update: 7:45 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NTLA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$258 | 65 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 63 BUY |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 63 BUY |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$128 | 59 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$51 | 50 HOLD |
Advanced NTLA Option Strategies
Professional options setups generated by AI based on today's NTLA price and gamma walls.
